Xiaolan Tian

Key Myositis Laboratories, No.2 Yinghua East Road, Chaoyang District
Beijing, 100029, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Tongue myositis in dermatomyositis with anti-PM-Scl 75 antibody: two case reports.

Tongue myositis in dermatomyositis with anti-PM-Scl 75 antibody: two case reports.

Journal: BMC musculoskeletal disorders

Published: May 03, 2025

Long-term outcomes of idiopathic inflammatory myopathies: a large-scale longitudinal cohort study.

Long-term outcomes of idiopathic inflammatory myopathies: a large-scale longitudinal cohort study.

Journal: Journal of autoimmunity

Published: January 02, 2025

Outcome of COVID-19 in patients with idiopathic inflammatory myopathy during the Omicron wave in China: A longitudinal observational study.

Outcome of COVID-19 in patients with idiopathic inflammatory myopathy during the Omicron wave in China: A longitudinal observational study.

Journal: PloS one

Published: August 14, 2024

Validation of the 2018 (New) ENMC Classification Criteria for Dermatomyositis in Chinese Patients with Idiopathic Inflammatory Myopathies.

Validation of the 2018 (New) ENMC Classification Criteria for Dermatomyositis in Chinese Patients with Idiopathic Inflammatory Myopathies.

Journal: Clinical rheumatology

Published: May 20, 2024

Polymyositis is a rare and favourable outcome subtype of idiopathic inflammatory myopathy in Chinese patients.

Polymyositis is a rare and favourable outcome subtype of idiopathic inflammatory myopathy in Chinese patients.

Journal: Clinical and experimental rheumatology

Published: December 02, 2023

Spontaneous pneumomediastinum in anti-MDA5-positive dermatomyositis: Prevalence, risk factors, and prognosis.

Spontaneous pneumomediastinum in anti-MDA5-positive dermatomyositis: Prevalence, risk factors, and prognosis.

Journal: Seminars in arthritis and rheumatism

Published: August 02, 2023

Distinct phenotype and prognosis of immune-mediated necrotizing myopathy based on clinical-serological-pathological classification.

Distinct phenotype and prognosis of immune-mediated necrotizing myopathy based on clinical-serological-pathological classification.

Journal: Rheumatology (Oxford, England)

Published: March 28, 2023

Peripheral lymphocyte count defines the clinical phenotypes and prognosis in patients with anti-MDA5-positive dermatomyositis.

Peripheral lymphocyte count defines the clinical phenotypes and prognosis in patients with anti-MDA5-positive dermatomyositis.

Journal: Journal of internal medicine

Published: January 22, 2023

Clinical characteristics of myositis patients with isolated anti-U1 ribonucleoprotein antibody resemble immune-mediated necrotizing myopathy.

Clinical characteristics of myositis patients with isolated anti-U1 ribonucleoprotein antibody resemble immune-mediated necrotizing myopathy.

Journal: Therapeutic advances in musculoskeletal disease

Published: January 21, 2023

Immunoproteasome subunit β5i promotes perifascicular muscle atrophy in dermatomyositis by upregulating RIG-I.

Immunoproteasome subunit β5i promotes perifascicular muscle atrophy in dermatomyositis by upregulating RIG-I.

Journal: RMD open

Published: October 23, 2022

Serum levels of anti-transcriptional intermediary factor 1-γ autoantibody associated with the clinical, pathological characteristics and outcomes of patients with dermatomyositis.

Serum levels of anti-transcriptional intermediary factor 1-γ autoantibody associated with the clinical, pathological characteristics and outcomes of patients with dermatomyositis.

Journal: Seminars in arthritis and rheumatism

Published: December 08, 2021

Clinical and pathological features of immune-mediated necrotising myopathies in a single-centre muscle biopsy cohort.

Clinical and pathological features of immune-mediated necrotising myopathies in a single-centre muscle biopsy cohort.

Journal: BMC musculoskeletal disorders

Published: November 20, 2021

Showing 1-12 of 20

Last Updated: 09/26/2026